Enlarge / A Merck sign stands in front of the company’s building on October 2, 2013, in Summit, New Jersey. (credit: Getty | Kena Betancur ) An oral antiviral drug appears to cut the risk of hospitalization and death from COVID-19 by roughly 50 percent in people newly diagnosed with the particular infection and at […]
